Acquisition by Avi Mazaltov of 52500 shares of VBI Vaccines subject to Rule 16b-3

VBIVQ Stock   0.0005  0.00  0.000004%   
Slightly above 61% of VBI Vaccines' investor base is looking to short. The analysis of the overall investor sentiment regarding VBI Vaccines suggests that many traders are alarmed. VBI Vaccines' investing sentiment overview a quick insight into current market opportunities from investing in VBI Vaccines. Many technical investors use VBI Vaccines stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Vbi Vaccines Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
VBI insider trading alert for grant of option right to buy common shares by Avi Mazaltov, Head Global MFGGM-SciVac Ltd., on 28th of July 2023. This event was filed by Vbi Vaccines Inc with SEC on 2023-07-28. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

VBI Vaccines' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the VBI Vaccines' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

VBI Vaccines Fundamental Analysis

We analyze VBI Vaccines' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VBI Vaccines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VBI Vaccines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

VBI Vaccines is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

VBI Vaccines Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VBI Vaccines stock to make a market-neutral strategy. Peer analysis of VBI Vaccines could also be used in its relative valuation, which is a method of valuing VBI Vaccines by comparing valuation metrics with similar companies.

Additional Tools for VBI Stock Analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.